Device Trial Radar · NCT03111550
Clinical Investigation of the Next-Generation Intraocular Lens
Last checked: Nov 19, 2026Latest source record: Jun 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
242
Actual
Start
May 10, 2017
Primary completion
Feb 23, 2018
Study completion Feb 23, 2018
Sponsor
- Lead sponsor
- Abbott Medical OpticsPublic (ABT)
- Sponsor type
- Industry
- First posted
- Apr 13, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a 6-month, prospective, multicenter, bilateral, randomized clinical investigation of the TECNIS Model ZHR00 and Model ZQR00 IOLs versus the TECNIS Symfony control IOL. The study was conducted at 12 sites in the U.S.A and treated approximately 240 subjects, equally split between the two test groups and the control group.
Conditions
- Cataract
Interventions
Investigational Intraocular Lens Device #1: TECNIS Model ZHR00Device
Intraocular lens replaces the natural lens removed during cataract surgery.
Investigational Intraocular Lens Device #2: TECNIS Model ZQR00Device
Intraocular lens replaces the natural lens removed during cataract surgery.
TECNIS Symfony® Extended Range of Vision Intraocular Lens: Model ZXR00Device
Intraocular lens replaces the natural lens removed during cataract surgery.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Monocular Distance Corrected Near Visual Acuity (DCNVA) at 40 cmTime frame: 1 month postoperative
- Rates of Adverse Events vs ISO (International Organization for Standardization) SPE ( Safety and Performance Endpoint) Rates (6-Month Persistent Medical Complications/Adverse Events vs ISO 11979-9 SPE Rates)Time frame: 6 months postoperative
- Rates of Adverse Events vs ISO SPE Rates (6-Month Cumulative Medical Complications/Adverse Events vs ISO 11979-9 SPE Rates)Time frame: 6 months postoperative
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Empire Eye and Laser Center
Bakersfield, California
Assil Eye Institute
Beverly Hills, California
Jones Eye Care
Sioux City, Iowa
9 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.